Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Topical
Emulsifying Agents
Thickeners and Stabilizers
Film Formers & Plasticizers
Surfactant & Foaming Agents
Co-Processed Excipients
Direct Compression
Rheology Modifiers
API Stability Enhancers
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Rimexolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rimexolone, including repackagers and relabelers. The FDA regulates Rimexolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rimexolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rimexolone supplier is an individual or a company that provides Rimexolone active pharmaceutical ingredient (API) or Rimexolone finished formulations upon request. The Rimexolone suppliers may include Rimexolone API manufacturers, exporters, distributors and traders.
click here to find a list of Rimexolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rimexolone DMF (Drug Master File) is a document detailing the whole manufacturing process of Rimexolone active pharmaceutical ingredient (API) in detail. Different forms of Rimexolone DMFs exist exist since differing nations have different regulations, such as Rimexolone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rimexolone DMF submitted to regulatory agencies in the US is known as a USDMF. Rimexolone USDMF includes data on Rimexolone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rimexolone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rimexolone suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rimexolone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rimexolone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rimexolone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rimexolone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rimexolone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rimexolone suppliers with NDC on PharmaCompass.
Rimexolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rimexolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rimexolone GMP manufacturer or Rimexolone GMP API supplier for your needs.
A Rimexolone CoA (Certificate of Analysis) is a formal document that attests to Rimexolone's compliance with Rimexolone specifications and serves as a tool for batch-level quality control.
Rimexolone CoA mostly includes findings from lab analyses of a specific batch. For each Rimexolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rimexolone may be tested according to a variety of international standards, such as European Pharmacopoeia (Rimexolone EP), Rimexolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rimexolone USP).
LOOKING FOR A SUPPLIER?
